This book uses new thinking on precision medicine and the interplay of genetic factors, the microbiome, and external triggers to build on the core concepts of inflammatory bowel disease. It outlines the latest findings in targeting therapies to the individual patient with Crohn¿s and colitis, management of chronic infections in the setting of immunomodulators and biologics, non-surgical therapy of dysplasia in colitis patients, and redefining and structuring the problematic pouch. In addition, this book features useful chapters dedicated to the economic aspects of IBD in an increasingly constrained healthcare system, as well as the patient experience and the role of subspecialist telemedicine care.

Discusses the current state of the art in the pathogenesis, diagnosis and management of inflammatory bowel disease (IBD)

Advances in Our Understanding of the Pathogenesis of Inflammatory Bowel Disease.- Diagnosis and monitoring in Inflammatory Bowel disease: who, when, where and how.- Ulcerative Colitis Diagnosis and Management: Past, Present and Future Directions.- New Developments in the Management of Crohn's Disease.- Extraintestinal Manifestations In Inflammatory Bowel Disease.- Infectious Complications in Inflammatory Bowel Disease.- Healthcare Maintenance in the Patient with Inflammatory Bowel Disease: High Yield Interventions.- The Woman With Inflamatory Bowel Disease: Fertility, Pregnancy And Beyond.- Unique Challenges in the Diagnosis and Management of the Pediatric IBD Patient.- Colon Cancer Screening and Surveillance in the IBD patient.- The Utility Of Endoscopy In Inflamatory Bowel Disease.- Changing Paradigms in the Management of the Elderly IBD Patient.- Surgical management of the complex Crohn's and ulcerative colitis patient: When to redo a pouch.- The Economics of IBD: IsThere a Future for a Medical Home?.- A Physician Patient's Perspective: Personal challenges and the role of sub-specialist telemedicine.- IBD in the time of COVID-19.